OncoLink en espanõl
Share
Types of Cancer > Head and Neck Cancers > Laryngeal Cancer > News
August 2009
Marijuana use linked to reduced risk of head and neck cancer
Pain in head and neck cancer patients may predict outcomes
June 2009
Pre-op smoking cessation improves head and neck surgery outcomes
March 2009
Chemotherapy alone may provide durable remission of laryngeal cancer
Gefitinib of no benefit in recurrent squamous cell carcinoma of head and neck
February 2009
Sequential and alternating chemoradiotherapy comparable for laryngeal cancer
January 2009
HPV-16 oncoprotein vaccine protects against head and neck cancer in mice
December 2008
Socioeconomic, racial disparities seen in head and neck cancer prognosis
November 2008
Chest CT scans help monitor spread of head and neck cancer
September 2008
Cetuximab improves survival of patients with head and neck cancer
August 2008
Postop alcohol withdrawal therapy can help head and neck cancer patients
July 2008
Targeted exercise improves function, lessens pain in head and neck cancer survivors
June 2008
Laryngeal papilloma relapse treatable with intralesional cidofovir
May 2008
Citalopram can prevent depression in head and neck cancer patients
April 2008
Bevacizumab can be added to chemoradiotherapy for head and neck cancer
March 2008
Different risk factors seen for HPV-positive and -negative head and neck cancer
January 2008
Salivary test for head and neck cancers has good sensitivity
Aspiration widespread in head and neck cancer patients
Aggressive treatment favored for advanced laryngeal cancer
December 2007
TP53 mutations linked to reduced survival for head and neck cancer
November 2007
Salvage therapy effective after failed radiotherapy for laryngeal cancer
September 2007
Impaired driving performance seen in head and neck cancer patients
Alcohol cessation cuts risk of esophageal or head and neck cancers
PET/CT reveals occult metastasis of head and neck cancer
June 2007
Erlotinib and cisplatin well-tolerated therapy for head and neck cancers
January 2007
Stroma-specific genetic alterations seen in head and neck SCC
November 2006
Aspirin use linked to a reduced risk of head and neck cancer
3-D radiation can reduce feeding tube need in head and neck cancers
Hypothyroidism linked to better survival in head and neck cancer
August 2006
Combined approach often effective for head and neck cancer
June 2006
Folic acid has chemopreventive effects in laryngeal leucoplakia
May 2006
Three-molecule complex activates pathways leading to head and neck cancers
PET and CT improve head and neck cancer targeting
Good survival rates with second course of radiation for head and neck cancers
April 2006
Low-dose isotretinoin no help against second primary head and neck tumors
Rehabilitation improves smell in total laryngectomy patients
March 2006
CORRECTED: FDA approves Erbitux for head and neck cancer
February 2006
Subcutaneous amifostine feasible during radiotherapy for head and neck cancer
Single-cycle induction chemo can guide treatment in advanced laryngeal cancer
Treatment selection may improve outcomes in laryngeal cancer
Tetracaine gel reduces oral pain after treatment of head and neck cancer
Cetuximab improves outcomes of head and neck cancers
January 2006
QOL after treatment of head and neck cancer predicts long-term survival
October 2005
Treatments for head and neck cancer result in similar quality of life
New treatment regimen boosts survival in recurrent head and neck cancer
August 2005
High osteopontin levels predict nimorazole response with head and neck cancer
Polycyclic aromatic hydrocarbon exposure increases laryngeal cancer risk
April 2005
E-cadherin predicts outcome of head and neck cancers
March 2005
Isotretinoin of no benefit in head and neck cancer
February 2005
Photodynamic therapy reduces severity of laryngeal papillomas
SPARC tied to reduced survival in head and neck cancer
January 2005
Gene profiling may improve treatment of head and neck cancer
December 2004
Cisplatin aids radiotherapy for head and neck cancer
November 2004
Neoadjuvant chemotherapy can improve head and neck cancer survival
Gastrectomy raises laryngeal cancer risk
October 2004
Genomic factors augment TNM staging in squamous cell head and neck cancer
Smoking history worsens survival of head and neck cancer
September 2004
Lymphangiogenesis may portend head and neck cancer metastasis
May 2004
Cisplatin plus radiation therapy improves head and neck cancer outcome
March 2004
HPV in oral exfoliated cells associated with head and neck cancer
January 2004
Erlotinib promising for advanced head and neck cancer
December 2003
HPV a separate risk factor for head and neck cancer
November 2003
Radiotherapy plus cisplatin preserves organ in advanced laryngeal cancer
Immunotherapy shows promise against head and neck cancer in mice
October 2003
Scintigraphic sentinal node mapping cost-effective for early head and neck cancer
Erythropoietin therapy may worsen prognosis of head and neck cancer
September 2003
Accelerated radiotherapy improves head and neck cancer outcomes
July 2003
Gastric resection may predispose to laryngeal cancer
May 2003
Prognostic factors for resected T3 laryngeal cancer identified
February 2003
Fiber intake may reduce risk of laryngeal cancer
Chemoradiation study aims for 80% survival in laryngeal cancer
January 2003
Sentinel lymph node mapping safe and reliable for melanoma of head and neck
August 2002
Cisplatin/epinephrine injectable gel shrinks head and neck cancer tumors
June 2002
Head and neck cancer rates increasing among US children
May 2002
Parotidectomy often needed in aggressive head and neck skin cancers
Combination regimen best organ preservation therapy for laryngeal cancer
April 2002
New biomarkers for ovarian, breast, and head and neck cancers identified
November 2001
H. pylori may increase laryngeal cancer risk
Radiation plus cisplatin improves survival in head and neck cancers
October 2001
Photodynamic therapy shows efficacy in head and neck cancers
Injectable cisplatin gel active in head and neck cancer
September 2001
IL-2 gene therapy efficacious against head and neck cancer in phase IIb
July 2001
Novel treatment strategy improves outcomes in head and neck cancer
New oral test detects genetic alterations predictive of oral and head and neck cancers
April 2001
Substandard care for laryngeal cancer therapy noted in some European centers
HPV-16 a possible risk factor for squamous-cell carcinoma of the head and neck
February 2001
Poromas may occur on head and neck area
October 2000
Accelerated radiation improves tumor control in head and neck cancer
September 2000
Accelerated radiation therapy preserves voice in head and neck cancer patients
August 2000
Twice daily radiation better than once daily for head and neck cancer
Cytokine drug could reduce head and neck tumors
Near-total laryngectomy can preserve voice
Depression, alcohol screens warranted for head and neck cancer patients
Gene therapy plus chemotherapy effective in treating head and neck cancer
June 2000
"Polite yawning" facilitates recovery of sense of smell after laryngectomy
Hypothyroidism develops in 15% of patients treated for advanced head and neck cancer
May 2000
HPV has etiologic role in some head and neck squamous cell carcinomas
April 2000
Antibody toxins inhibit growth of head and neck cancer cells and induce tumor regression
Chemoradiotherapy controls local spread of advanced head and neck cancer
Role of HPV infection in laryngeal carcinoma still unclear
March 2000
PH-20 hyaluronidase may be tumor marker for laryngeal cancer
November 1999
Chemo plus radiation boosts survival in some head and neck cancer patients
May 1999
Use of alternative medicine common among head and neck cancer patients
February 1999
Lilly's MTA promising treatment for head and neck cancer, NSC lung cancer
January 1999